TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 8, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 3
- 0 vs. Q1 2025
- Portfolio value
- $163.3M
- +$70.5M (+75.9%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 16,859,075 | $86.3M | 52.9% | 00.0% | Unchanged | History |
| MAZEMaze Therapeutics, Inc. | COM | 6,073,958 | $74.5M | 45.6% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $2.47M | 1.5% | 00.0% | Unchanged | History |